Alves-Silva Juliana, Tavares Isabela P, Guimarães Erika S, Costa Franco Miriam M, Figueiredo Barbara C, Marques João T, Splitter Gary, Oliveira Sergio C
Departamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, United States.
Front Microbiol. 2017 Nov 14;8:2217. doi: 10.3389/fmicb.2017.02217. eCollection 2017.
The microtubule (MT) cytoskeleton regulates several cellular processes related to the immune system. For instance, an intricate intracellular transport mediated by MTs is responsible for the proper localization of vesicular receptors of innate immunity and its adaptor proteins. In the present study, we used nocodazole to induce MTs depolymerization and paclitaxel or recombinant (r) TIR (Toll/interleukin-1 receptor) domain containing protein (TcpB) to induce MT stabilization in bone marrow-derived macrophages infected with . Following treatment of the cells, we evaluated their effects on pathogen intracellular replication and survival, and in pro-inflammatory cytokine production. First, we observed that intracellular trafficking and maturation of -containing vesicles (BCVs) is affected by partial destabilization or stabilization of the MTs network. A typical marker of early BCVs, LAMP-1, is retained in late BCVs even 24 h after infection in the presence of low doses of nocodazole or paclitaxel and in the presence of different amounts of rTcpB. Second, microscopy and colony forming unit analysis revealed that bacterial load was increased in infected macrophages treated with lower doses of nocodazole or paclitaxel and with rTcpB compared to untreated cells. Third, innate immune responses were also affected by disturbing MT dynamics. MT depolymerization by nocodazole reduced IL-12 production in infected macrophages. Conversely, rTcpB-treated cells augmented IL-12 and IL-1β secretion in infected cells. In summary, these findings demonstrate that modulation of MTs affects several crucial steps of pathogenesis, including BCV maturation, intracellular survival and IL-12 secretion in infected macrophages.
微管(MT)细胞骨架调节与免疫系统相关的多种细胞过程。例如,由微管介导的复杂细胞内运输负责先天免疫囊泡受体及其衔接蛋白的正确定位。在本研究中,我们使用诺考达唑诱导微管解聚,并使用紫杉醇或含重组(r)TIR(Toll/白细胞介素-1受体)结构域的蛋白(TcpB)诱导感染了[病原体名称未给出]的骨髓来源巨噬细胞中的微管稳定。对细胞进行处理后,我们评估了它们对病原体细胞内复制和存活以及促炎细胞因子产生的影响。首先,我们观察到含[病原体名称未给出]囊泡(BCVs)的细胞内运输和成熟受到微管网络部分去稳定化或稳定化的影响。即使在低剂量诺考达唑或紫杉醇存在以及不同量rTcpB存在的情况下感染后24小时,早期BCVs的典型标志物LAMP-1仍保留在晚期BCVs中。其次,显微镜检查和集落形成单位分析表明,与未处理的细胞相比,用较低剂量诺考达唑或紫杉醇以及rTcpB处理的感染巨噬细胞中的细菌载量增加。第三,先天免疫反应也受到微管动力学干扰的影响。诺考达唑使微管解聚降低了感染巨噬细胞中IL-12的产生。相反,rTcpB处理的细胞增加了感染细胞中IL-12和IL-1β的分泌。总之,这些发现表明微管的调节影响了[病原体名称未给出]发病机制的几个关键步骤,包括BCV成熟、细胞内存活以及感染巨噬细胞中IL-12的分泌。